Contact Us
 | Site Map
Not A Member?
Advanced Search

Notice: The ASA website will be unavailable beginning Thursday, May 17 from 4 p.m. until noon (CDT) on May 18 due to system maintenance.

Set Content Text to the Largest Size
Set Content Text to a Larger Size
Set Content Text to Default Size
Print This Page's Content
Bookmark This Page
>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS

October 13 - 17 2012, 12:00 AM - 12:00 AM

ANESTHESIOLOGY 2012

>

FDA MEDWATCH ALERTS

RSS

May 16, 2012

Hydromorphone Hydrochloride Recall

Summary:

Hydromorphone Hydrochloride Recall

April 18, 2012

Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall - May Contain More Than Intended Fill Volume

Summary:

Customer report of two Carpujects syringes containing more than the 1 mL labeled fill volume. Opioid pain medications such as morphine have life-threatening consequences if overdosed. Those consequences can include respiratory depression (slowed breathing or suspension of breathing), and low blood pressure.

March 05, 2012

Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators (AEDs): Class I Recall - Defective Component

Summary: FDA notified healthcare professionals and medical care organizations of the Class 1 recall of the listed AEDs which contain a component that may fail unexpectedly due to a defect. If the component were to fail during a rescue attempt, the AED may not deliver defibrillation therapy, causing serious adverse health consequences, including death. The unit’s self test may not detect the failure or impending failure of the component.

View all »

>

ASA FEATURED PRODUCT

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-12CE

... Read more »

Single Copies, Member Price: $300

Office of General Counsel

The Office of General Counsel (OGC) is responsible for the legal affairs of ASA.  The OGC represents the Society on a broad range of legal issues, including but not limited to:

  • Administration of the Expert Witness Testimony Review Program
  • Review and negotiation of all Society contracts
  • Intellectual Property matters
  • Antitrust concerns
  • Tax law matters
  • Nonprofit corporate legal issues
  • Governance

This page includes links to important information and resources regarding the Society’s expert witness and intellectual property programs. For further information or questions regarding the OGC, please contact the General Counsel, Ronald Szabat, JD, LLM, in the Washington, D.C., office at (202) 289-2222 or by e-mail.

 

ASA Antitrust Statement

ASA Copyright Policy 

License Information for CROSSWALK®, Reverse CROSSWALK, and Relative Value Guide®

Expert Witness Testimony Review Program

About ASA: The American Society of Anesthesiologists is an educational, research and scientific association of physicians organized to raise and maintain the standards of the medical practice of anesthesiology and improve the care of the patient. Since its founding in 1905, the Society's achievements have made it an important voice in American Medicine and the foremost advocate for all patients who require anesthesia or relief from pain.